Wu F, Bui K C, Buckley S, Warburton D
Division of Neonatology and Pediatric Pulmonology, Childrens Hospital of Los Angeles, University of Southern California School of Medicine 90027.
Am J Respir Cell Mol Biol. 1994 Apr;10(4):437-47. doi: 10.1165/ajrcmb.10.4.8136159.
Cyclin D1, which is suggested to have a role in G1 control during the cell cycle, is genetically linked to BCL-1 and is widely overexpressed in parathyroid, breast, and squamous cancer cells. We postulated that cyclin D1 regulation may also be important in lung cancer. Therefore, we characterized the cell cycle-dependent expression of cyclin D1 at both mRNA and protein levels in synchronized human A549 lung carcinoma cells. Monospecific anti-cyclin D1 C-terminal peptide antibodies recognized both p36cyclinD1 and an as-yet uncharacterized 45 kD protein (p45). A549 cells were synchronized with well-studied drugs. Cyclin D1 mRNA expression remained relatively constant, with less than a twofold fluctuation during the cell cycle and with a minor peak at M phase. However, the p36cyclinD1 protein fluctuated during the A549 cell cycle and was expressed at very low levels in late G1 and at the G1/S boundary, but then increased in S phase and peaked at M phase. In contrast, p45 protein was expressed at relatively high levels in late G1 and reached maximal levels at the G1/S boundary, was expressed at decreased levels in S phase, and then had disappeared by M phase. Moreover, p45 was highly expressed only in transformed alveolar epithelial cells, but not in normal rat alveolar epithelial cells or fetal rat lung fibroblasts in primary cultures. In mink Mv1Lu cells, the expression of p45 was totally blocked by transforming growth factor-beta 1 treatment or contact inhibition. p45 protein was phosphorylated on serine, threonine, and tyrosine residues in A549 cells in culture. The phosphorylation of the p45 protein was cell cycle-regulated and reached its maximal levels at G2/M phase. The p45 protein had a different peptide map from p36cyclinD1 after cleavage with N-chlorosuccinimide. Immunoprecipitation studies showed that p45 was also anti-ubiquitin immunoreactive during the cell cycle. We conclude that p36cyclinD1 and the p45 protein are differentially regulated in a cell cycle-dependent manner in A549 cells. Although p45 is antigenically related to p36cyclinD1, it is probably not a closely cyclin-related protein. We speculate that p45 may be associated with malignant transformation and may play a distinct role from p36cyclinD1 in regulation of the cell cycle in A549 cells.
细胞周期蛋白D1被认为在细胞周期的G1期调控中发挥作用,它在基因上与BCL-1相关联,并且在甲状旁腺、乳腺和鳞状癌细胞中广泛过度表达。我们推测细胞周期蛋白D1的调控在肺癌中可能也很重要。因此,我们在同步化的人A549肺癌细胞中,从mRNA和蛋白质水平对细胞周期蛋白D1的细胞周期依赖性表达进行了表征。单特异性抗细胞周期蛋白D1 C末端肽抗体识别p36细胞周期蛋白D1和一种尚未鉴定的45 kD蛋白(p45)。A549细胞用研究充分的药物进行同步化处理。细胞周期蛋白D1 mRNA表达相对保持恒定,在细胞周期中波动小于两倍,在M期有一个小峰值。然而,p36细胞周期蛋白D1蛋白在A549细胞周期中波动,在G1晚期和G1/S边界处表达水平非常低,但随后在S期增加并在M期达到峰值。相比之下,p45蛋白在G1晚期表达水平相对较高,在G1/S边界处达到最高水平,在S期表达水平降低,然后在M期消失。此外,p45仅在转化的肺泡上皮细胞中高表达,而在原代培养的正常大鼠肺泡上皮细胞或胎鼠肺成纤维细胞中不表达。在貂Mv1Lu细胞中,转化生长因子-β1处理或接触抑制可完全阻断p45的表达。培养的A549细胞中,p45蛋白在丝氨酸、苏氨酸和酪氨酸残基上发生磷酸化。p45蛋白的磷酸化受细胞周期调控,在G2/M期达到最高水平。用N-氯代琥珀酰亚胺裂解后,p45蛋白与p36细胞周期蛋白D1具有不同的肽图。免疫沉淀研究表明,在细胞周期中p45也具有抗泛素免疫反应性。我们得出结论,在A549细胞中,p36细胞周期蛋白D1和p45蛋白以细胞周期依赖性方式受到不同的调控。尽管p45在抗原性上与p36细胞周期蛋白D1相关,但它可能不是一种与细胞周期蛋白密切相关的蛋白。我们推测p45可能与恶性转化有关,并且在A549细胞的细胞周期调控中可能发挥与p36细胞周期蛋白D1不同的作用。